Pharmaceuticals
Company Overview of Potentia Pharmaceuticals, Inc.
Company Overview
Potentia Pharmaceuticals, Inc., an early stage biotechnology company, develops anti-inflammatory drugs in the areas of age-related macular degeneration, atherosclerosis, uveitis, rheumatoid arthritis, multiple sclerosis, and Alzheimer's disease. Its product includes POT-4, which is used for the treatment of age-related macular degeneration. Potentia Pharmaceuticals, Inc. was founded in 2001 and is based in Louisville, Kentucky.
201 East Jefferson Street
Suite 312
Louisville, KY 40202
United States
Founded in 2001
Key Executives for Potentia Pharmaceuticals, Inc.
Similar Private Companies By Industry
| Company Name | Region |
| BioSamPle Solutions LLC | United States |
| Prexa Pharmaceuticals, Inc. | United States |
| BioCrystal, Ltd. | United States |
| ImClone Systems Corporation | United States |
| AOB Biotech Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Gainesville, FL | AstraZenecaPosted: May 23
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact Potentia Pharmaceuticals, Inc., please visit www.potentiapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
